2017-2022 North America Alzheimer’s Disease Drug Market Report

November 2017 | 119 pages | ID: 22FB6D39882EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In 2016, the North America Alzheimer’s Disease Drug market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022.

This report studies Alzheimer’s Disease Drug in North America market, especially in United States, Canada and Mexico, focuses on the top players in each country, covering

• Allergan
• Eisai
• Novartis
• Daiichi Sankyo
• Merz Pharma
• Pfizer
• Johnson & Johnson
• Lundbeck.

Market Segment by Countries, this report splits North America into several key Countries, with sales, revenue, market share of top players in these Countries, from 2012 to 2017 (forecast), like

• United States
• Canada
• Mexico

Split by Product Types, with sales, revenue, price, market share of each type, can be divided into

• Donepezil
• Memantine
• Rivastigmine

Split by applications, this report focuses on sales, market share and growth rate of Alzheimer’s Disease Drug in each application, can be divided into

• Early to Moderate Stages
• Moderate to Severe Stages

Contents

1 ALZHEIMER’S DISEASE DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Alzheimer’s Disease Drug
1.2 Alzheimer’s Disease Drug Segment by Types
  1.2.1 North America Sales Market Share of Alzheimer’s Disease Drug by Types in 2016
  1.2.2 Donepezil
    1.2.2.1 Major Players of Donepezil
  1.2.3 Memantine
    1.2.3.1 Major Players of Memantine
  1.2.4 Rivastigmine
    1.2.4.1 Major Players of Rivastigmine
1.3 Alzheimer’s Disease Drug Segment by Applications
  1.3.1 Alzheimer’s Disease Drug Sales Market Share by Applications in 2016
  1.3.2 Early to Moderate Stages
  1.3.3 Moderate to Severe Stages
1.4 Alzheimer’s Disease Drug Market by Countries
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 Canada Status and Prospect (2012-2022)
  1.4.3 Mexico Status and Prospect (2012-2022)
1.5 North America Alzheimer’s Disease Drug Overview and Market Size (Value) (2012-2022)
  1.5.1 North America Market Alzheimer’s Disease Drug Overview
  1.5.2 North America Market Alzheimer’s Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)

2 NORTH AMERICA ALZHEIMER’S DISEASE DRUG SALES, REVENUE (VALUE) AND MARKET SHARE BY PLAYERS

2.1 North America Alzheimer’s Disease Drug Sales and Market Share in 2016 and 2017 by Players
2.2 North America Alzheimer’s Disease Drug Revenue and Market Share by Players in 2016 and 2017
2.3 North America Alzheimer’s Disease Drug Average Price by Players in 2016 and 2017
2.4 North America Alzheimer’s Disease Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
2.5 Alzheimer’s Disease Drug Market Competitive Situation and Trends
  2.5.1 Alzheimer’s Disease Drug Market Concentration Rate
  2.5.2 Alzheimer’s Disease Drug Market Share of Top 3 and Top 5 Players
  2.5.3 Mergers & Acquisitions, Expansion

3 NORTH AMERICA ALZHEIMER’S DISEASE DRUG SALES, REVENUE (VALUE) BY COUNTRIES, TYPE AND APPLICATION (2012-2017)

3.1 North America Alzheimer’s Disease Drug Sales, Revenue and Market Share by Countries (2012-2017)
  3.1.1 North America Alzheimer’s Disease Drug Sales and Market Share by Countries (2012-2017)
  3.1.2 North America Alzheimer’s Disease Drug Revenue and Market Share by Countries (2012-2017)
  3.1.3 North America Alzheimer’s Disease Drug Price by Countries (2012-2017)
3.2 North America Alzheimer’s Disease Drug Sales, Revenue, Market Share and Price by Type (2012-2017)
  3.2.1 North America Alzheimer’s Disease Drug Sales and Market Share by Type (2012-2017)
  3.2.2 North America Alzheimer’s Disease Drug Revenue and Market Share by Type (2012-2017)
  3.2.3 North America Alzheimer’s Disease Drug Price by Type (2012-2017)
3.3 North America Alzheimer’s Disease Drug Sales and Market Share by Application (2012-2017)
3.4 North America Market Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)

4 NORTH AMERICA ALZHEIMER’S DISEASE DRUG PLAYERS PROFILES/ANALYSIS

4.1 Allergan
  4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.1.2 Alzheimer’s Disease Drug Product Types, Application and Specification
    4.1.2.1 Type
    4.1.2.2 Type
  4.1.3 Allergan Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.1.4 Main Business/Business Overview
  4.1.5 Allergan News
4.2 Eisai
  4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.2.2 Alzheimer’s Disease Drug Product Types, Application and Specification
    4.2.2.1 Type
    4.2.2.2 Type
  4.2.3 Eisai Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.2.4 Main Business/Business Overview
  4.2.5 Eisai News
4.3 Novartis
  4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.3.2 Alzheimer’s Disease Drug Product Types, Application and Specification
    4.3.2.1 Type
    4.3.2.2 Type
  4.3.3 Novartis Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.3.4 Main Business/Business Overview
  4.3.5 Novartis News
4.4 Daiichi Sankyo
  4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.4.2 Alzheimer’s Disease Drug Product Types, Application and Specification
    4.4.2.1 Type
    4.4.2.2 Type
  4.4.3 Daiichi Sankyo Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.4.4 Main Business/Business Overview
  4.4.5 Daiichi Sankyo News
4.5 Merz Pharma
  4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.5.2 Alzheimer’s Disease Drug Product Types, Application and Specification
    4.5.2.1 Type
    4.5.2.2 Type
  4.5.3 Merz Pharma Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.5.4 Main Business/Business Overview
  4.5.5 Merz Pharma News
4.6 Pfizer
  4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.6.2 Alzheimer’s Disease Drug Product Types, Application and Specification
    4.6.2.1 Type
    4.6.2.2 Type
  4.6.3 Pfizer Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.6.4 Main Business/Business Overview
  4.6.5 Pfizer News
4.7 Johnson & Johnson
  4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.7.2 Alzheimer’s Disease Drug Product Types, Application and Specification
    4.7.2.1 Type
    4.7.2.2 Type
  4.7.3 Johnson & Johnson Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.7.4 Main Business/Business Overview
  4.7.5 Johnson & Johnson News
4.8 Lundbeck.
  4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.8.2 Alzheimer’s Disease Drug Product Types, Application and Specification
    4.8.2.1 Type
    4.8.2.2 Type
  4.8.3 Lundbeck. Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.8.4 Main Business/Business Overview
  4.8.5 Lundbeck. News

5 UNITED STATES ALZHEIMER’S DISEASE DRUG SALES, REVENUE (VALUE) BY TYPE AND APPLICATION (2012-2017)

5.1 United States Alzheimer’s Disease Drug Sales, Revenue and Growth Rate (2012-2017)
5.2 United States Alzheimer’s Disease Drug Sales, Revenue and Market Share by Type (2012-2017)
  5.2.1 United States Alzheimer’s Disease Drug Sales and Market Share by Type (2012-2017)
  5.2.2 United States Alzheimer’s Disease Drug Revenue and Market Share by Type (2012-2017)
  5.2.3 United States Alzheimer’s Disease Drug Price by Type (2012-2017)
5.3 United States Alzheimer’s Disease Drug Sales and Market Share by Application (2012-2017)

6 CANADA ALZHEIMER’S DISEASE DRUG SALES, REVENUE (VALUE) BY TYPE AND APPLICATION (2012-2017)

6.1 Canada Alzheimer’s Disease Drug Sales, Revenue and Growth Rate (2012-2017)
6.2 Canada Alzheimer’s Disease Drug Sales, Revenue and Market Share by Type (2012-2017)
  6.2.1 Canada Alzheimer’s Disease Drug Sales and Market Share by Type (2012-2017)
  6.2.2 Canada Alzheimer’s Disease Drug Revenue and Market Share by Type (2012-2017)
  6.2.3 Canada Alzheimer’s Disease Drug Price by Type (2012-2017)
6.3 Canada Alzheimer’s Disease Drug Sales and Market Share by Application (2012-2017)

7 MEXICO ALZHEIMER’S DISEASE DRUG SALES, REVENUE (VALUE) BY TYPE AND APPLICATION (2012-2017)

7.1 Mexico Alzheimer’s Disease Drug Sales, Revenue and Growth Rate (2012-2017)
7.2 Mexico Alzheimer’s Disease Drug Sales, Revenue and Market Share by Type (2012-2017)
  7.2.1 Mexico Alzheimer’s Disease Drug Sales and Market Share by Type (2012-2017)
  7.2.2 Mexico Alzheimer’s Disease Drug Revenue and Market Share by Type (2012-2017)
  7.2.3 Mexico Alzheimer’s Disease Drug Price by Type (2012-2017)
7.3 Mexico Alzheimer’s Disease Drug Sales and Market Share by Application (2012-2017)

8 NORTH AMERICA ALZHEIMER’S DISEASE DRUG MARKET FORECAST (2017-2022)

8.1 North America Alzheimer’s Disease Drug Sales, Revenue Forecast (2017-2022)
8.2 North America Alzheimer’s Disease Drug Sales, Sales Forecast by Countries (2017-2022)
8.3 North America Alzheimer’s Disease Drug Sales Forecast by Type (2017-2022)
8.4 North America Alzheimer’s Disease Drug Sales Forecast by Application (2017-2022)
8.5 Alzheimer’s Disease Drug Price Forecast (2017-2022)

9 ALZHEIMER’S DISEASE DRUG MANUFACTURING COST ANALYSIS

9.1 Alzheimer’s Disease Drug Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Alzheimer’s Disease Drug

10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 Alzheimer’s Disease Drug Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Alzheimer’s Disease Drug Major Players in 2016
10.4 Downstream Buyers

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Alzheimer’s Disease Drug
Table Product Specifications of Alzheimer’s Disease Drug
='Figure North America Sales Market Share of '&Sheet1!B1&' by Types in 2016
Table Types of Alzheimer’s Disease Drug
Figure Product Picture of Donepezil
Table Major Players of Donepezil
Figure Product Picture of Memantine
Table Major Players of Memantine
Figure Product Picture of Rivastigmine
Table Major Players of Rivastigmine
Figure Alzheimer’s Disease Drug Sales Market Share by Applications in 2016
='Table Applications of '&Sheet1!B1&'
Figure Early to Moderate Stages Examples
Figure Moderate to Severe Stages Examples
Figure United States Alzheimer’s Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Alzheimer’s Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Alzheimer’s Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure North America Alzheimer’s Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Table North America Alzheimer’s Disease Drug Sales by Players in 2016 and 2017
Table North America Alzheimer’s Disease Drug Sales Market Share (%) by Players in 2016 and 2017
Figure North America Alzheimer’s Disease Drug Sales Market Share by Players in 2016
Figure North America Alzheimer’s Disease Drug Sales Market Share by Players in 2017
Table North America Alzheimer’s Disease Drug Revenue by Players in 2016 and 2017
Table North America Alzheimer’s Disease Drug Revenue Market Share (%) by Players in 2016 and 2017
Figure North America Alzheimer’s Disease Drug Revenue Market Share by Players in 2016
Figure North America Alzheimer’s Disease Drug Revenue Market Share by Players in 2017
Table North America Alzheimer’s Disease Drug Average Price by Players in 2016 and 2017
Figure North America Alzheimer’s Disease Drug Average Price by Players in 2016
Table North America Alzheimer’s Disease Drug Manufacturing Base Distribution and Sales Area by Players
Table Players Alzheimer’s Disease Drug Product Types
Figure Alzheimer’s Disease Drug Market Share of Top 3 Players
Figure Alzheimer’s Disease Drug Market Share of Top 5 Players
Table North America Alzheimer’s Disease Drug Sales by Countries (2012-2017)
Table North America Alzheimer’s Disease Drug Sales Market Share by Countries (2012-2017)
Figure North America Alzheimer’s Disease Drug Sales Market Share by Countries (2012)
Figure North America Alzheimer’s Disease Drug Sales Market Share by Countries (2016)
Table North America Alzheimer’s Disease Drug Revenue by Countries (2012-2017)
Table North America Alzheimer’s Disease Drug Revenue Market Share by Countries (2012-2017)
Figure 2012 North America Alzheimer’s Disease Drug Revenue Market Share by Countries
Figure 2016 North America Alzheimer’s Disease Drug Revenue Market Share by Countries
Table North America Alzheimer’s Disease Drug Price by Countries (2012-2017)
Table North America Alzheimer’s Disease Drug Sales by Type (2012-2017)
Table North America Alzheimer’s Disease Drug Sales Market Share by Type (2012-2017)
Figure 2012 North America Alzheimer’s Disease Drug Sales Market Share by Type
Figure 2016 North America Alzheimer’s Disease Drug Sales Market Share by Type
Table North America Alzheimer’s Disease Drug Revenue by Type (2012-2017)
Table North America Alzheimer’s Disease Drug Revenue Market Share by Type (2012-2017)
Figure 2012 North America Alzheimer’s Disease Drug Revenue Market Share by Type
Figure 2016 North America Alzheimer’s Disease Drug Revenue Market Share by Type
Table North America Alzheimer’s Disease Drug Price by Type (2012-2017)
Table North America Alzheimer’s Disease Drug Sales by Application (2012-2017)
Table North America Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017)
Figure North America Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017)
Table North America Market Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Allergan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Allergan Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Allergan Alzheimer’s Disease Drug Market Share (2012-2017)
Table Eisai Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eisai Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eisai Alzheimer’s Disease Drug Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Alzheimer’s Disease Drug Market Share (2012-2017)
Table Daiichi Sankyo Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Daiichi Sankyo Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Daiichi Sankyo Alzheimer’s Disease Drug Market Share (2012-2017)
Table Merz Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merz Pharma Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merz Pharma Alzheimer’s Disease Drug Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Alzheimer’s Disease Drug Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson & Johnson Alzheimer’s Disease Drug Market Share (2012-2017)
Table Lundbeck. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lundbeck. Alzheimer’s Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Lundbeck. Alzheimer’s Disease Drug Market Share (2012-2017)
Figure United States Alzheimer’s Disease Drug Sales and Growth Rate (2012-2017)
Figure United States Alzheimer’s Disease Drug Revenue and Growth Rate (2012-2017)
Table United States Alzheimer’s Disease Drug Sales by Type (2012-2017)
Table United States Alzheimer’s Disease Drug Sales Market Share by Type (2012-2017)
Figure United States Alzheimer’s Disease Drug Sales Market Share by Type (2012-2017)
Table United States Alzheimer’s Disease Drug Revenue by Type (2012-2017)
Table United States Alzheimer’s Disease Drug Revenue Market Share by Type (2012-2017)
Figure United States Alzheimer’s Disease Drug Revenue Market Share by Type (2012-2017)
Table United States Alzheimer’s Disease Drug Price by Type (2012-2017)
Table United States Alzheimer’s Disease Drug Sales by Application (2012-2017)
Table United States Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017)
Figure United States Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017)
Figure Canada Alzheimer’s Disease Drug Sales and Growth Rate (2012-2017)
Figure Canada Alzheimer’s Disease Drug Revenue and Growth Rate (2012-2017)
Table Canada Alzheimer’s Disease Drug Sales by Type (2012-2017)
Table Canada Alzheimer’s Disease Drug Sales Market Share by Type (2012-2017)
Figure Canada Alzheimer’s Disease Drug Sales Market Share by Type (2012-2017)
Table Canada Alzheimer’s Disease Drug Revenue by Type (2012-2017)
Table Canada Alzheimer’s Disease Drug Revenue Market Share by Type (2012-2017)
Figure Canada Alzheimer’s Disease Drug Revenue Market Share by Type (2012-2017)
Table Canada Alzheimer’s Disease Drug Price by Type (2012-2017)
Table Canada Alzheimer’s Disease Drug Sales by Application (2012-2017)
Table Canada Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017)
Figure Canada Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017)
Figure Mexico Alzheimer’s Disease Drug Sales and Growth Rate (2012-2017)
Figure Mexico Alzheimer’s Disease Drug Revenue and Growth Rate (2012-2017)
Table Mexico Alzheimer’s Disease Drug Sales by Type (2012-2017)
Table Mexico Alzheimer’s Disease Drug Sales Market Share by Type (2012-2017)
Figure Mexico Alzheimer’s Disease Drug Sales Market Share by Type (2012-2017)
Table Mexico Alzheimer’s Disease Drug Revenue by Type (2012-2017)
Table Mexico Alzheimer’s Disease Drug Revenue Market Share by Type (2012-2017)
Figure Mexico Alzheimer’s Disease Drug Revenue Market Share by Type (2012-2017)
Figure 2016 Mexico Alzheimer’s Disease Drug Revenue Market Share by Type
Table Mexico Alzheimer’s Disease Drug Price by Type (2012-2017)
Table Mexico Alzheimer’s Disease Drug Sales by Application (2012-2017)
Table Mexico Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017)
Figure Mexico Alzheimer’s Disease Drug Sales Market Share by Application (2012-2017)
Figure North America Alzheimer’s Disease Drug Sales and Growth Rate Forecast (2017-2022)
Figure North America Alzheimer’s Disease Drug Revenue and Growth Rate Forecast (2017-2022)
Table North America Alzheimer’s Disease Drug Sales Forecast by Countries (2017-2022)
Table North America Alzheimer’s Disease Drug Sales Market Share Forecast by Countries (2017-2022)
Table North America Alzheimer’s Disease Drug Sales Forecast by Type (2017-2022)
Table North America Alzheimer’s Disease Drug Sales Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Alzheimer’s Disease Drug
Figure Manufacturing Process Analysis of Alzheimer’s Disease Drug
Figure Alzheimer’s Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Alzheimer’s Disease Drug Major Players in 2016
Table Major Buyers of Alzheimer’s Disease Drug
Table Distributors/Traders List